 | • レポートコード：QYR9N8124 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、チゲサイクリン薬のグローバル市場について調査・分析したレポートで、種類別（TYGACIL、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・チゲサイクリン薬の世界市場規模 ・主要企業別市場シェア ・チゲサイクリン薬の世界市場規模：種類別（TYGACIL、ジェネリック） ・チゲサイクリン薬の世界市場規模：用途別（病院、ドラッグストア） ・チゲサイクリン薬のアメリカ市場規模（種類別、用途別） ・チゲサイクリン薬のヨーロッパ市場規模（種類別、用途別） ・チゲサイクリン薬の中国市場規模（種類別、用途別） ・チゲサイクリン薬の日本市場規模（種類別、用途別） ・チゲサイクリン薬の東南アジア市場規模（種類別、用途別） ・チゲサイクリン薬のインド市場規模（種類別、用途別） ・チゲサイクリン薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・チゲサイクリン薬の世界市場予測（2019年-2025年） ・チゲサイクリン薬の地域別市場予測（2019年-2025年） ... |
Tigecycline is an antibiotic for a number of bacterial infections. It is a glycylcycline administered intravenously. It was developed in response to the growing rate of antibiotic resistant bacteria such as Staphylococcus aureus, Acinetobacter baumannii, and E. coli. In 2018, the global Tigecycline Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Tigecycline Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tigecycline Drug development in United States, Europe and China.
The key players covered in this study
Pfizer
Sandoz
Apotex
Fresenius Kabi
Accord Healthcare
Amneal
Zhejiang Hisun Pharmaceutical
Nanjing Hicin Pharmaceutical
CTTQ Pharma
Market segment by Type, the product can be split into
TYGACIL
Generic
Market segment by Application, split into
Hospital
Drug store
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Tigecycline Drug status, future forecast, growth opportunity, key market and key players.
To present the Tigecycline Drug development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Tigecycline Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tigecycline Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 TYGACIL
1.4.3 Generic
1.5 Market by Application
1.5.1 Global Tigecycline Drug Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Drug store
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Tigecycline Drug Market Size
2.2 Tigecycline Drug Growth Trends by Regions
2.2.1 Tigecycline Drug Market Size by Regions (2014-2025)
2.2.2 Tigecycline Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Tigecycline Drug Market Size by Manufacturers
3.1.1 Global Tigecycline Drug Revenue by Manufacturers (2014-2019)
3.1.2 Global Tigecycline Drug Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tigecycline Drug Market Concentration Ratio (CR5 and HHI)
3.2 Tigecycline Drug Key Players Head office and Area Served
3.3 Key Players Tigecycline Drug Product/Solution/Service
3.4 Date of Enter into Tigecycline Drug Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Tigecycline Drug Market Size by Type (2014-2019)
4.2 Global Tigecycline Drug Market Size by Application (2014-2019)
5 United States
5.1 United States Tigecycline Drug Market Size (2014-2019)
5.2 Tigecycline Drug Key Players in United States
5.3 United States Tigecycline Drug Market Size by Type
5.4 United States Tigecycline Drug Market Size by Application
6 Europe
6.1 Europe Tigecycline Drug Market Size (2014-2019)
6.2 Tigecycline Drug Key Players in Europe
6.3 Europe Tigecycline Drug Market Size by Type
6.4 Europe Tigecycline Drug Market Size by Application
7 China
7.1 China Tigecycline Drug Market Size (2014-2019)
7.2 Tigecycline Drug Key Players in China
7.3 China Tigecycline Drug Market Size by Type
7.4 China Tigecycline Drug Market Size by Application
8 Japan
8.1 Japan Tigecycline Drug Market Size (2014-2019)
8.2 Tigecycline Drug Key Players in Japan
8.3 Japan Tigecycline Drug Market Size by Type
8.4 Japan Tigecycline Drug Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Tigecycline Drug Market Size (2014-2019)
9.2 Tigecycline Drug Key Players in Southeast Asia
9.3 Southeast Asia Tigecycline Drug Market Size by Type
9.4 Southeast Asia Tigecycline Drug Market Size by Application
10 India
10.1 India Tigecycline Drug Market Size (2014-2019)
10.2 Tigecycline Drug Key Players in India
10.3 India Tigecycline Drug Market Size by Type
10.4 India Tigecycline Drug Market Size by Application
11 Central & South America
11.1 Central & South America Tigecycline Drug Market Size (2014-2019)
11.2 Tigecycline Drug Key Players in Central & South America
11.3 Central & South America Tigecycline Drug Market Size by Type
11.4 Central & South America Tigecycline Drug Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tigecycline Drug Introduction
12.1.4 Pfizer Revenue in Tigecycline Drug Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Sandoz
12.2.1 Sandoz Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tigecycline Drug Introduction
12.2.4 Sandoz Revenue in Tigecycline Drug Business (2014-2019)
12.2.5 Sandoz Recent Development
12.3 Apotex
12.3.1 Apotex Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tigecycline Drug Introduction
12.3.4 Apotex Revenue in Tigecycline Drug Business (2014-2019)
12.3.5 Apotex Recent Development
12.4 Fresenius Kabi
12.4.1 Fresenius Kabi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tigecycline Drug Introduction
12.4.4 Fresenius Kabi Revenue in Tigecycline Drug Business (2014-2019)
12.4.5 Fresenius Kabi Recent Development
12.5 Accord Healthcare
12.5.1 Accord Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tigecycline Drug Introduction
12.5.4 Accord Healthcare Revenue in Tigecycline Drug Business (2014-2019)
12.5.5 Accord Healthcare Recent Development
12.6 Amneal
12.6.1 Amneal Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tigecycline Drug Introduction
12.6.4 Amneal Revenue in Tigecycline Drug Business (2014-2019)
12.6.5 Amneal Recent Development
12.7 Zhejiang Hisun Pharmaceutical
12.7.1 Zhejiang Hisun Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tigecycline Drug Introduction
12.7.4 Zhejiang Hisun Pharmaceutical Revenue in Tigecycline Drug Business (2014-2019)
12.7.5 Zhejiang Hisun Pharmaceutical Recent Development
12.8 Nanjing Hicin Pharmaceutical
12.8.1 Nanjing Hicin Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tigecycline Drug Introduction
12.8.4 Nanjing Hicin Pharmaceutical Revenue in Tigecycline Drug Business (2014-2019)
12.8.5 Nanjing Hicin Pharmaceutical Recent Development
12.9 CTTQ Pharma
12.9.1 CTTQ Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tigecycline Drug Introduction
12.9.4 CTTQ Pharma Revenue in Tigecycline Drug Business (2014-2019)
12.9.5 CTTQ Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Tigecycline Drug Key Market Segments
Table Key Players Tigecycline Drug Covered
Table Global Tigecycline Drug Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tigecycline Drug Market Size Market Share by Type 2014-2025
Figure TYGACIL Figures
Table Key Players of TYGACIL
Figure Generic Figures
Table Key Players of Generic
Table Global Tigecycline Drug Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Drug store Case Studies
Figure Tigecycline Drug Report Years Considered
Table Global Tigecycline Drug Market Size 2014-2025 (Million US$)
Figure Global Tigecycline Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tigecycline Drug Market Size by Regions 2014-2025 (Million US$)
Table Global Tigecycline Drug Market Size by Regions 2014-2019 (Million US$)
Table Global Tigecycline Drug Market Share by Regions 2014-2019
Figure Global Tigecycline Drug Market Share by Regions 2014-2019
Figure Global Tigecycline Drug Market Share by Regions 2019
Table Market Top Trends
Table Global Tigecycline Drug Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tigecycline Drug Market Share by Manufacturers (2014-2019)
Figure Global Tigecycline Drug Market Share by Manufacturers in 2018
Table Global Tigecycline Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tigecycline Drug Product/Solution/Service
Table Date of Enter into Tigecycline Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table Global Tigecycline Drug Market Size Share by Type (2014-2019)
Figure Global Tigecycline Drug Market Size Market Share by Type (2014-2019)
Table Global Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table Global Tigecycline Drug Market Size Share by Application (2014-2019)
Figure Global Tigecycline Drug Market Size Market Share by Application (2014-2019)
Figure Global Tigecycline Drug Revenue Market Share by Application in 2018
Figure United States Tigecycline Drug Market Size 2014-2019 (Million US$)
Table United States Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table United States Key Players Tigecycline Drug Market Share (2018-2019)
Table United States Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table United States Tigecycline Drug Market Share by Type (2014-2019)
Table United States Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table United States Tigecycline Drug Market Share by Application (2014-2019)
Figure Europe Tigecycline Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Tigecycline Drug Market Share (2018-2019)
Table Europe Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table Europe Tigecycline Drug Market Share by Type (2014-2019)
Table Europe Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table Europe Tigecycline Drug Market Share by Application (2014-2019)
Figure China Tigecycline Drug Market Size 2014-2019 (Million US$)
Table China Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table China Key Players Tigecycline Drug Market Share (2018-2019)
Table China Tigecycline Drug Market Size by Type (2014-20189) (Million US$)
Table China Tigecycline Drug Market Share by Type (2014-2019)
Table China Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table China Tigecycline Drug Market Share by Application (2014-2019)
Figure Japan Tigecycline Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Tigecycline Drug Market Share (2018-2019)
Table Japan Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table Japan Tigecycline Drug Market Share by Type (2014-2019)
Table Japan Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table Japan Tigecycline Drug Market Share by Application (2014-2019)
Figure Southeast Asia Tigecycline Drug Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tigecycline Drug Market Share (2018-2019)
Table Southeast Asia Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tigecycline Drug Market Share by Type (2014-2019)
Table Southeast Asia Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tigecycline Drug Market Share by Application (2014-2019)
Figure India Tigecycline Drug Market Size 2014-2019 (Million US$)
Table India Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table India Key Players Tigecycline Drug Market Share (2018-2019)
Table India Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table India Tigecycline Drug Market Share by Type (2014-2019)
Table India Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table India Tigecycline Drug Market Share by Application (2014-2019)
Figure Central & South America Tigecycline Drug Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tigecycline Drug Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tigecycline Drug Market Share (2018-2019)
Table Central & South America Tigecycline Drug Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tigecycline Drug Market Share by Type (2014-2019)
Table Central & South America Tigecycline Drug Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tigecycline Drug Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Tigecycline Drug Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Pfizer Recent Development
Table Sandoz Company Details
Table Sandoz Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Sandoz Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Sandoz Recent Development
Table Apotex Company Details
Table Apotex Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Apotex Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Apotex Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Fresenius Kabi Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Fresenius Kabi Recent Development
Table Accord Healthcare Company Details
Table Accord Healthcare Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Accord Healthcare Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Accord Healthcare Recent Development
Table Amneal Company Details
Table Amneal Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Amneal Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Amneal Recent Development
Table Zhejiang Hisun Pharmaceutical Company Details
Table Zhejiang Hisun Pharmaceutical Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Zhejiang Hisun Pharmaceutical Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Zhejiang Hisun Pharmaceutical Recent Development
Table Nanjing Hicin Pharmaceutical Company Details
Table Nanjing Hicin Pharmaceutical Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure Nanjing Hicin Pharmaceutical Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table Nanjing Hicin Pharmaceutical Recent Development
Table CTTQ Pharma Company Details
Table CTTQ Pharma Revenue in Tigecycline Drug Business (2014-2019)(Million US$)
Figure CTTQ Pharma Revenue Growth Rate in Tigecycline Drug Business (2014-2019)
Table CTTQ Pharma Recent Development
Table Global Tigecycline Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Tigecycline Drug Market Size Share by Regions (2019-2025)
Figure Global Tigecycline Drug Market Size Share by Regions in 2025
Figure United States Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure India Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tigecycline Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Tigecycline Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Tigecycline Drug Market Size by Product (2019-2025)
Figure Global Tigecycline Drug Market Size by Product in 2025
Table Global Tigecycline Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Tigecycline Drug Market Size by Application (2019-2025)
Figure Global Tigecycline Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界のデシタビン薬市場：市場規模・現状・予測 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).In 2018, the global Decitabine…
- 世界のシクロベンザプリン薬市場：市場規模・現状・予測 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
- 世界のレボセチリジン薬市場：市場規模・現状・予測 Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.In 2018, t…
- 世界の鎮痛剤デリバリー市場：市場規模・現状・予測 Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or…